(RTTNews) - United Therapeutics Corp. (UTHR) said that it has prevailed in dry powder inhaler patent litigation with Liquidia Technologies. United Therapeutics noted that the United States District ...

There was a notable gap in effectiveness between metered-dose and dry-powder formulations of single-inhaler triple therapy for chronic obstructive pulmonary disease (COPD), according to real-world ...

NEW YORK A new inhaler being unveiled by Valois Pharma is being touted as more user friendly, while delivering the medication in an easier and safer way, according to published reports. Prohaler is a ...

Tyvaso DPI is an investigational drug-device combination therapy consisting of a dry powder formulation of treprostinil. The Food and Drug Administration (FDA) has accepted for Priority Review the New ...

LEXINGTON, Mass.--Pulmatrix, a biotechnology company developing breakthrough therapies for respiratory diseases, today announced that its iSPERSE™ inhaled drug delivery platform demonstrated the ...